UnitedHealth Group Soars on Q1 Earnings, But Is It Still Undervalued?

UnitedHealth Group (UNH) has gained fresh confidence following its robust Q1 earnings, which have started to deliver results for the business. The company's reported US$3b artificial intelligence spend is a crucial factor in this success. Despite the strong Q1 update, UnitedHealth Group's share price has been choppy in the short term, with a 2.4% decline over the past month and 2.5% drop over 90 days.

However, the year-to-date share price return of 18.1% and 1-year total shareholder return of 17.2% indicate improved momentum over recent months compared to the longer 3- and 5-year total returns. UnitedHealth Group's sharp year-to-date climb contrasts with its softer 3-year track record and recent pullback.

Analysts' consensus price target for UnitedHealth Group stands at $475.23 per share, based on expectations of future earnings growth, profit margins, and other risk factors. However, there is a significant degree of disagreement amongst analysts, with the most bullish reporting a price target of $529.0 and the most bearish targeting just $313.0.